Agreement creates runway for Profound’s incision-free and radiation-free therapies for the ablation of diseased tissue, to penetrate the largest healthcare market in the Middle East ...
Scientists at The Wistar Institute have solved a longstanding puzzle in ovarian cancer treatment: why anti-estrogen therapy ...
Uterine fibroids (also known as leiomyomas or myomas) are non-cancerous tumors that develop in or on the uterus .
While you can't see endometriosis adhesions from a scan, they can still cause big problems. Patients usually describe having ...
In a reversal, the Food and Drug Administration has removed black box warnings on hormone replacement therapies for menopause ...
TriSalus Life Sciences, Inc. (Nasdaq: TLSI) ("TriSalus" or the "Company"), an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for patients ...
Studies reveal how the Lunit SCOPE® suite identifies immunotherapy-responsive subtypes, standardizes immune phenotyping, and ...
Modern obstetric advances have improved labor management with pain medication integration, yet gynecologic pain management ...
It is a silent killer of Australian women, but a major national report out Monday shows a staggering 94 per cent surveyed at ...
Stage 2 endometrial cancer spreads to the cervical stroma but remains within the uterus and cervix, requiring precise staging and diagnosis. Treatment typically involves surgery, possibly a radical ...
Uterine fibroids, common non-cancerous growths, can cause significant discomfort for women of childbearing age. Key symptoms ...
Researchers from Rutgers Cancer Institute, New Jersey’s only National Cancer Institute (NCI) - designated Comprehensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback